Gefitinib Long-term Survivor Study

Trial Identifier: D7913R00020
Sponsor: AstraZeneca
NCTID:: NCT02932345
Start Date: October 2016
Primary Completion Date: July 2017
Study Completion Date: July 2017
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China, Beijing Beijing, China
China, Fujian Fuzhou, Fujian, China
China, Guangdong Guangzhou, Guangdong, China
China, He nan Zhengzhou, He nan, China
China, Hebei Shijiazhuang, Hebei, China
China, Hubei Wuhan, Hubei, China
China, Jiangsu Nanjing, Jiangsu, China
China, Jilin Changchun, Jilin, China
China, Liaoning Shenyang, Liaoning, China
China, Shaanxi Xi an, Shaanxi, China
China, Shanghai Shanghai, China
China, Shanxi Taiyuan, Shanxi, China
China, Sichuan Chengdu, Sichuan, China
China, Zhejiang Hangzhou, Zhejiang, China